PHARMACY

Cardinal Health announces new scholarship program to benefit pharmacy schools

BY Michael Johnsen

DUBLIN, Ohio — Cardinal Health on Friday announced a new pharmacy college scholarship program, making $1.1 million in scholarship funds available to 13 pharmacy schools. Recipient schools will be endowed with scholarship funding ranging from $50,000 to $125,000.

Five-of-the-13 pharmacy schools that received funding were selected because of their commitment to advancing the independent pharmacy profession. These schools offer curricula focused on operating an independent pharmacy, support student-run chapters of the National Community Pharmacists Association, endorse internship and co-op programs with local independent retail pharmacies, and demonstrate high post-graduate placement rates in community pharmacy settings.

Several of the selected pharmacy schools were chosen because of their strong nuclear pharmacy programs, while others were picked because of their strong hospital pharmacy programs.

“Cardinal Health serves more than 7,000 community pharmacists across the country, and we’re one of the nation’s largest employers of nuclear and hospital pharmacists,” stated Mike Kaufmann, CEO of Cardinal Health’s pharmaceutical segment. “We passionately believe in the essential role pharmacists play in making sure patients receive safe, high-quality health care. That’s why we’re proud to partner with some of our nation’s best universities to invest in developing tomorrow’s pharmacy leaders.”

Schools receiving scholarship funding in Cardinal Health’s Pharmacy Scholarship Program include:

  • East Tennessee State University’s Bill Gatton College of Pharmacy (Johnson City, Tenn.);

  • Long Island University’s Arnold & Marie Schwartz College of Pharmacy and Health Sciences (Brooklyn, N.Y.);

  • Ohio Northern University’s Raabe College of Pharmacy (Ada, Ohio);

  • Ohio State University College of Pharmacy (Columbus, Ohio);

  • Philadelphia College of Pharmacy at University of the Sciences (Philadelphia);

  • Purdue University College of Pharmacy (West Lafayette, Ind.);

  • University of Arizona College of Pharmacy (Tucson, Ariz.);

  • University of Florida College of Pharmacy (Gainesville, Fla.);

  • University of Mississippi School of Pharmacy (Oxford, Miss.);

  • University of New Mexico College of Pharmacy (Albuquerque, N.M.);

  • University of Tennessee at Memphis (Memphis, Tenn.);

  • University of Texas at Austin College of Pharmacy (Austin, Texas); and

  • Washington State University College of Pharmacy (Pullman, Wash.).

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

NACDS debuts new app for 2011 Marketplace Conference

BY Antoinette Alexander

ALEXANDRIA, Va. — The National Association of Chain Drug Stores has launched its 2011 Marketplace Web-based mobile application, which is designed to enhance attendees’ efficiency and experience at the NACDS Marketplace Conference from June 25 to 28 in Boston.

The first NACDS mobile app was introduced for the NACDS 2010 Annual Meeting.

In addition, the NACDS mobile website, m.NACDS.org, is updated with information about the upcoming conference and all 2011 NACDS events.

"NACDS continues to explore innovative ways to enhance its member programs and services," NACDS president and CEO Steve Anderson said. "Utilizing technology is an important way to maximize the continued value and experience that NACDS members expect from NACDS meetings and conferences."

The NACDS mobile app is compatible with most smartphone platforms, including iPhone, Droid and Blackberry devices, and can be downloaded for free on m.NACDS.org or from NACDS’ main website, NACDS.org. The NACDS mobile website serves as a "guide on the go" to NACDS meetings, advocacy and communications. Marketplace attendees will find planning tools for the event, including an updated schedule, floor plan, list of participants and sponsors.

The site is specifically designed for ease of use on any smartphone with a Web browser.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Abbott: LCIG may improve Parkinson’s disease symptoms among patients

BY Alaric DeArment

ABBOTT PARK, Ill. — Patients with Parkinson’s disease treated with an investigational drug made by Abbott saw a decrease in the amount of time their symptoms resurfaced, while the time in which their symptoms stayed under control increased, according to results of a late-stage clinical trial that Abbott announced Thursday.

The 192-patient trial was a 54-week, phase-3 study of levodopa-carbidopa intestinal gel, or LCIG. As Parkinson’s patients’ disease progresses during treatment with oral medications, they usually will experience “off” time, when some of their symptoms re-emerge. This contrasts with “on” time, when their symptoms are well-managed. They also may experience involuntary movements associated with most treatments used to manage the disease, known as dyskinesias, which can result from spikes in drug levels in the blood caused by inconsistent absorption of oral medications.

After 12 weeks of therapy, patients reported an average of 3.9 fewer hours of “off” time and 4.6 more hours of “on” time without troublesome dyskinesias.

LCIG is infused with a portable pump directly into the small intestine via a small tube during daytime hours, and continuous delivery may help reduce drug-level spikes, thus reducing dyskinesias.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?